By THE ASSOCIATED PRESS
Pfizer is buying Hospira for approximately $15.23 billion, saying it is a good fit with its global established pharmaceutical business.
Published: February 5, 2015 at 02:17AM
from NYT Business Day http://ift.tt/1I8huCM
from WordPress http://ift.tt/1zjtQSI
No comments:
Post a Comment